KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Research & Development (2016 - 2025)

Historic Research & Development for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $4.3 billion.

  • Johnson & Johnson's Research & Development fell 1974.33% to $4.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $14.7 billion, marking a year-over-year decrease of 1489.67%. This contributed to the annual value of $14.7 billion for FY2025, which is 1489.67% down from last year.
  • As of Q4 2025, Johnson & Johnson's Research & Development stood at $4.3 billion, which was down 1974.33% from $3.7 billion recorded in Q3 2025.
  • Johnson & Johnson's 5-year Research & Development high stood at $5.3 billion for Q4 2024, and its period low was $3.2 billion during Q2 2021.
  • For the 5-year period, Johnson & Johnson's Research & Development averaged around $3.8 billion, with its median value being $3.5 billion (2024).
  • Per our database at Business Quant, Johnson & Johnson's Research & Development soared by 4366.12% in 2024 and then plummeted by 2584.81% in 2025.
  • Quarter analysis of 5 years shows Johnson & Johnson's Research & Development stood at $3.4 billion in 2021, then increased by 1.84% to $3.5 billion in 2022, then rose by 28.55% to $4.5 billion in 2023, then increased by 18.26% to $5.3 billion in 2024, then fell by 19.74% to $4.3 billion in 2025.
  • Its Research & Development stands at $4.3 billion for Q4 2025, versus $3.7 billion for Q3 2025 and $3.5 billion for Q2 2025.